Top stories

Good news: Corona need not fear, indigenous Kovacin, including Kovishield, approved by DGCI

India, fighting Corona, today received two new weapons in the form of vaccines. Following the recommendations of the expert committee, the Drug Controller General of India (DCGI) has approved India’s Biotech for the Serum Institute of India and Kovacin for emergency use in India. Also, the Zydus Cadillac vaccine ‘Zykov-D’ has been approved for third stage clinical trials. DCGI Director VG Somani said that these vaccines are safe to use, so there is no need to be afraid if someone shows mild side effects.

Shortly after the vaccine was approved, Prime Minister Narendra Modi tweeted and congratulated the country, describing it as a day of pride for every Indian.

After the vaccine was approved for use, Serum Institute of India CEO Adar Punawala thanked Prime Minister Modi and wrote, ‘Happy New Year to all! In the end, the risk that the corona vaccine has taken today has been met. Coveshield will be available for use in the coming weeks. ‘

The committee has given the green signal to the domestic vaccine

Earlier on Saturday, it was reported that the expert committee had approved the use of India Biotech’s Indigenous Corona Vaccine Center. However, the final approval of the DG has not been received yet.

On Friday, the coronavirus vaccine ‘Covishield’, developed by the Serum Institute of India, including Oxford University and AstraZeneca, was approved for emergency use.

Union Health Minister Dr Harsh Vardhan also said on Saturday that about 30 million people across the country would be vaccinated against coronavirus free of cost in the first phase. Also, he said that no protocol will be compromised before approval.

Vaccine trials are currently underway in the country

Clinical trials of six coronary vaccines are currently underway in India. These include covishield and covacin. The Covishield Astroxy Vaccine, developed by AstraZeneca and the Serum Institute of India, Pune. Kovaxin is a desi vaccine developed in collaboration with the Indian Biotech of Indian Medical Research Council.

In addition to these two, Cadillac Health Care Limited of Ahmedabad is developing in collaboration with Zykovi-D Biotechnology Department. Also NVX-Covey 2373 is developing Serum Institute in collaboration with NovaMax. There are two more vaccines, one of which has been developed by Biological E Limited of Hyderabad in association with MIT, USA. The second HDT has been developed by Pune-based Genova Biopharmaceuticals Limited in collaboration with USA.

.

Show More

Related Articles

Leave a Reply

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker